Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Hypercontractile phenotype in hypertrophic cardiomyopathy indicates unfavorable hemodynamics, coronary flow and prognosis
Wierzbowska‐Drabik, Karina , D’Alfonso, Maria Grazia , Mori, Fabio , Vazquez, Jesus Peteiro , Re, Federica , Djordjevic‐Dikic, Ana , Rosa, Sílvia Aguiar , Cruz, Inês , Lopes, Luís R. , Arruda‐Olson, Adelaide M. , Yin, Lixue , Tripepi, Giovanni Luigi, Broncel, Marlena , Bartolacelli, Ylenia , Picano, Eugenio , Rodriguez-Zanella, Hugo , Lopes, Luis Rocha , Arruda-Olson, Adelaide, Pepi, Mauro , Pellikka, Patricia, Olivotto, Iacopo , Wierzbowska-Drabik, Karina , Pálinkás, Eszter Dalma , Franco, Annamaria Del , Tešić, Milorad , Pálinkás, Attila , Losi, Maria Angela , Rodríguez‐Zanella, Hugo , Nemes, Attila , Wang, Yi , Carerj, Scipione , Ciampi, Quirino , Pellikka, Patricia A. , Olivotto, Iacopo

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | August 26, 2025 | Volume: 26 | Issue: 10 | Pages: 1675-1684

10.1093/ehjci/jeaf238 | PMID 40878541 Get It

Abstract Aims Our aim was to assess the clinical and prognostic significance of the left ventricular (LV) hypercontractile phenotype (HP) in hypertrophic cardiomyopathy (HCM), which until now remains unclear. Methods and results We enrolled 1533 HCM patients (age 51 ± 15 years, 965 males, 63%) with ejection fraction (EF) ≥ 50%, referred for rest transthoracic echocardiography (TTE) in 27 laboratories from 13 countries. Two-dimensional volumetric TTE assessment included LV outflow tract gradient (LVOTG), LV EF, and LV force (systolic blood pressure + LVOTG/ESV, mmHg/mL). HP was defined as the highest quartile of the force (> 7.32 mmHg/mL). Survival analysis was performed in a subset of 1200 patients with follow-up information. Compared with non-HP patients, HP showed higher heart rate (72 ± 14 vs. 67 ± 14 beats per minute, P < 0.001), lower stroke volume (50 ± 22 vs. 67 ± 22 mL, P < 0.001), larger left atrial volume index (44 ± 16 vs. 40 ± 16 mL/m2, P = 0.011) and higher coronary flow velocity in the mid-distal left anterior descending artery (n = 325, 41 ± 12 vs. 37 ± 14 cm/s, P = 0.021). Force was moderately related to LV EF (r = 0.48, P < 0.001) and weakly to LVOTG (r = 0.36, P < 0.001). During a median follow-up of 87 months (interquartile range 45–143 months), 131 all-cause deaths occurred. At multivariable Cox analysis, a force > 7.32 mmHg (the fourth quartile for analyzed patients) was associated with a hazard ratio of 1.44 (95% Confidence intervals 1.00–2.07) for all-cause death, independently of LVOTG and LV EF. Conclusion HP in HCM is associated with a disadvantageous systemic, cardiac and coronary hemodynamic profile as well as lower survival in the long-term.
Evolution of cystic lung disease in Birt–Hogg–Dubé syndrome: assessment of older patients
Tzilas, Vasilios , Wang, Rui , Ryu, Jay H. , Ryu, Jay H , Wei, Wei , Hu, Xiaowen

Mayo Clinic

BMJ Open Respiratory Research | August 26, 2025 | Volume: 12 | Issue: 1 | Pages: e002629

10.1136/bmjresp-2024-002629 | PMID 40854806 Get It

Background Birt–Hogg–Dubé syndrome (BHD) is a rare autosomal dominant disease characterised by the development of lung cysts, skin fibrofolliculomas and an increased risk for renal cancer. The progression of cystic lung disease with ageing in BHD has not been well characterised. Objectives To assess the severity of lung involvement in patients with BHD aged 50 years or older. Methods A retrospective computer-assisted search was performed to identify patients with BHD seen at Mayo Clinic in Rochester, Minnesota and the First Affiliated Hospital of University of Science and Technology of China from January 2000 to May 2023. Demographic, clinical, pulmonary function and radiological parameters were extracted and analysed. Results Among 82 patients with BHD aged 50 years or older, 49 (59%) were female and the median age was 57 years (range, 50–79) at baseline. Pneumothorax occurred in 46 patients (56%). Lung cysts were observed on CT in 77 patients (94%) and were bilateral in nearly all cases. The number of cysts was≥10 for most patients (84%) and the median size of the largest cyst was 31 mm (range, 4–160 mm). Median (range) % predicted values of forced vital capacity, forced expiratory volume in 1 s and diffusion capacity of the lung for carbon monoxide were 98 (62–147), 92 (56–145) and 85 (61–133), respectively, for those with data available. During follow-up (median, 41 months; range, 3–259), 35% of patients manifested worsening in pulmonary function or cystic lung disease. Conclusion Lung involvement in older patients with BHD manifests varying severity of cystic lung disease with relatively mild functional impairment, if any, and indolent progression.
Outcomes Associated With SGLT2 Inhibitor Use Following Acute Myocardial Infarction Without Heart Failure: A Propensity-Matched Study
Issa, Rochell , Calcagno, Tess , Canova, Tyler , Issa, Ryan, Menon, Venu , Griffin, Brian P. , Kwon, Deborah , Wang, Tom Kai Ming , Wang, Tom Kai Ming , Kaelber, David C. , Tang, W.H. Wilson

Mayo Clinic

Angiology | August 25, 2025 | Volume: 77 | Issue: 6 | Pages: 704-713

10.1177/00033197251365016 | PMID 40852947 Get It

This retrospective propensity-matched cohort study assessed the association between sodium-glucose co-transporter-2 inhibitor (SGLT2i) use and cardiovascular outcomes in patients with acute myocardial infarction (AMI) without a history of heart failure. Using the TriNetX U.S. Collaborative Network, we identified 1440 matched patients (720 SGLT2i+ vs 720 SGLT2i−) with preserved ejection fraction and no prior heart failure. Nearly 90% of patients had diabetes. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of MI, stroke, heart failure, and all-cause mortality. At 1 year, MACE occurred in 17.4% of SGLT2i+ versus 22.0% of SGLT2i− patients (odds ratio [OR] 0.746, 95% CI 0.574-0.969; P = .028), and all-cause mortality occurred in 3.1% versus 7.6%, respectively (OR 0.389, 95% CI 0.234-0.645; P < .001). SGLT2i use was also associated with lower risks of major bleeding. Findings were consistent over long-term follow-up. While the observed associations suggest potential cardioprotective effects of SGLT2i post-MI in patients without heart failure, residual confounding cannot be excluded. The observed reduction in bleeding events is novel and warrants further investigation in prospective studies.
Genetic and Cellular Architecture of Breast Cancer Risk Across Ancestries
Zanti, Maria , Williams, Jacob , Jahagirdar, Om , Turcan, Alistair, Brandenburg, Jean‐Tristan , Li, Jingmei, Miranda, Patricio , Godbole, Devika , Zhang, Xiaomeng , Dorling, Leila , Dennis, Joe, John, Esther M. , Kushi, Lawrence H., Carvajal‐Carmona, Luis G. , Haiman, Christopher A. , Ziv, Elad , Easton, Douglas F. , Chanock, Stephen J., Chatterjee, Nilanjan , Kraft, Peter, Wong, Wendy S W , Zhu, Qianqian , Ahearn, Thomas U., Li, Jingmei , Zhang, Haoyu , John, Esther M , Li, Jingmei , Ziv, Elad , Li, James , Jia, Guochong , Hu, Qiang , Li, Yàn , Ho, Weang-Kee , Dias, Julie‐Alexia , Chen, Wenlong Carl , Boddicker, Nicholas , Wang, Ying , Martin, Alicia R. , Zhang, Yan , Torres-Mejı́a, Gabriela , Kushi, Lawrence H, Weitzel, Jeffrey N. , Neuhausen, Susan L. , Fejerman, Laura , Zheng, Wei , Huo, Dezheng , Chanock, Stephen Jacob , Chatterjee, Nilanjan , García‐Closas, Montserrat , Michailidou, Kyriaki , Zhang, Martin Jinye , Dutta, Diptavo , Ahearn, Thomas U.

Mayo Clinic

No container title available | August 25, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.08.20.25334075 | PMID 40909829 Get It

Abstract Background Breast cancer genome-wide association studies (GWAS) have identified more than 200 susceptibility loci, but most studies are dominated by European and East Asian populations. Methods We analyzed breast cancer GWAS summary statistics from African (AFR), East Asian (EAS), European (EUR), and Hispanic/Latina (H/L) samples (159,297 cases and 212,102 controls). We estimated logit-scale SNP-based heritability, polygenicity, and cross-ancestry genetic correlation, partitioned heritability across functional annotations, and integrated GWAS results with the Tabula Sapiens single-cell atlas using scDRS+. Results The logit-scale heritability of breast cancer ranged from ℎ 2 =0.47 (SE = 0.07) in EAS to AFR ℎ 2 =0.61 (SE = 0.10), with no significant differences across ancestries (p=0.63). The estimated number of susceptibility markers in a sparse normal-mixture effects model also varied from 4,446 (SE = 3,100) in EAS to 8,308 (SE = 2,751) in AFR, but differences were not significant across ancestries (p=0.55). Cross-sample genetic correlations varied, with the strongest correlation between EUR and EAS (𝜌 = 0.79, SE = 0.08) and weakest between AFR and H/L (𝜌 = 0.26, SE = 0.24). Regulatory annotations were enriched for breast cancer heritability across samples. Integration with single-cell expression profiles implicated ancestry-shared associations with innate immune, secretory epithelial, and stromal cell types. Conclusion These results indicate substantial cross-ancestry sharing of breast cancer polygenic architecture, highlight a consistent contribution of regulatory variation, and identify convergent cellular contexts that motivate functional follow-up and inform expectations for the transferability and attainable performance of common-variant risk prediction across populations.
Associations of High Attenuation Area–Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities
Debban, Catherine L., Guzman, Daniel E., Hannan, Riley T. , Salvatore, Mary , Zhang, David , Podolanczuk, Anna J. , Ma, Shwu‐Fan , Huang, Yong , Rotter, Jerome I., Dubin, Ruth F. , Wang, Jennifer M. , Han, MeiLan K., Noth, Imre , Woodruff, Prescott G. , Ortega, Victor E. , Fanburg–Smith, Julie C. , Stelow, Edward B. , Moskaluk, Christopher A. , Hoffman, Eric A. , Barr, R. Graham , Hannan, Riley T , Zhang, David , Podolanczuk, Anna J , Ma, Shwu-Fan , Pugashetti, Janelle Vu , Wang, Jennifer M , Oldham, Justin M , Hoffman, Eric A , Garcia, Christine K , Kim, John S. , McGroder, Claire F. , Duprez, Daniel A. , Sturek, Jeffrey M , Rich, Stephen S. , Rotter, Jerome I. , Deo, Rajat , Han, MeiLan King , Bowler, Russell P. , Ganz, Peter , Manichaikul, Ani

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | August 22, 2025 | Volume: 211 | Issue: 10 | Pages: 1811-1822

10.1164/rccm.202503-0610oc | PMID 40845333 Get It

Abstract Rationale High-attenuation area (HAA) is a computed tomography (CT) tool that correlates with lung inflammation and fibrosis. Systemic molecular correlates of HAA (e.g., plasma proteins) may inform biological processes involved in interstitial lung disease. Objectives To identify plasma proteins that associate with HAA and correlate with a higher probability of developing new-onset fibrotic or subpleural interstitial lung abnormalities (ILAs). Methods Plasma protein levels were measured using a semiquantitative aptamer-based platform in MESA (the Multi-Ethnic Study of Atherosclerosis; N = 5,486) and SPIROMICS (Subpopulations and Intermediate Outcome Measures in COPD Study; N = 1,781). Linear regression models identified HAA-associated proteins after adjustment for demographic and socioeconomic factors, CT scanner parameters, study center, and batch. Associations of HAA-related proteins with new-onset fibrotic or subpleural ILAs were examined in MESA participants with ILA assessments on full-lung CT 10 years later. Immunohistochemical staining of select proteins was performed in lung tissue from pulmonary fibrosis cases. Measurements and Main Results There were 75 proteins detected that were significantly associated with HAA in MESA and SPIROMICS. Gene Ontology analysis of these proteins identified processes involved in immune cell chemotaxis and cellular growth and apoptosis. Seven proteins were associated with a higher probability of new-onset fibrotic or subpleural ILAs in MESA, and two of these, junctional adhesion molecule-like protein and GTP cyclohydrolase 1 feedback regulatory protein, stained in areas of fibrosis in lung tissue from patients with interstitial lung disease. Conclusions Plasma proteins associated with more HAA are involved in immune and cellular processes and associate with new-onset fibrotic-subpleural ILA.
Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett’s esophagus
Tanes, Ceylan , Ginsberg, Gregory G. , Wang, Kenneth K. , Iyer, Prasad G. , Lightdale, C, Portillo, Armando Del , Lagana, Stephen M. , Rustgi, Anil K. , Quante, Michael , Jin, Zhezhen , Wu, Gary D. , Bittinger, Kyle, Abrams, Julian A , Li, Yun , Falk, Gary W. , Wang, Timothy C. , Friedman, Elliot S. , Li, Hongzhe

Mayo Clinic

Gut Microbes | August 22, 2025 | Volume: 17 | Issue: 1 | Pages: No page available

10.1080/19490976.2025.2545420 | PMID 40844321 Get It

Intracardiac thrombosis and its management during liver transplantation: international, multicenter, case-control study
Prete, Luca Del , Cazzaniga, Beatrice , Aniskevich, Stephen , Agopian, Vatche G. , Smith, Natalie , Cacioppo, Brian J, Nuti, Anna Maria, Wang, Ryan , Gamboa, Bs Sophia, Groose, Molly K. , Sheth, Mansi, Cywiński, Jacek B. , Wray, Christopher , Hashimoto, Koji , Liu, Qiang , Quintini, Cristiano , Del Prete, Luca , Agopian, Vatche G , Smith, Natalie K , Tu, Chao , Groose, Molly K , Cywinski, Jacek B , Nguyen-Buckley, Christine , Florman, Sander S , Liu, Qiang , Ekser, Burcin , Aniskevich, Stephen , Cacioppo, Brian J., Watson, Christopher, Pai, Sher‐Lu , Nguyen, Christine , Florman, Sander , Croome, Kristopher P. , Ekser, Burcin

Mayo Clinic

International Journal of Surgery | August 22, 2025 | Volume: 111 | Issue: 12 | Pages: 8793-8805

10.1097/js9.0000000000002896 | PMID 40844270 Get It

Background: Intracardiac thrombosis (ICT) during liver transplantation (LT) is a rare but life-threatening complication with limited data regarding its risk factors, management, and outcomes. This study aimed to identify factors associated with ICT development, define predictors of intraoperative outcomes, and propose a novel classification and management algorithm for ICT. Methods: A multicenter, international retrospective case-control study was conducted on liver transplant recipients from seven centers between January 2005 and December 2023. ICT cases were identified through transesophageal echocardiography (TEE) or autopsy and matched 1:1 with controls. Results: Among 11 077 liver transplant recipients screened, 133 patients (1.2%) developed ICT. ICT occurred predominantly after reperfusion (58%). Compared to controls, ICT cases exhibited higher preoperative international normalized ratio ( P = 0.001) and fibrinogen levels ( P = 0.014). Post-reperfusion syndrome ( P < 0.001), disseminated intravascular coagulation ( P < 0.001), and primary graft failure ( P = 0.002) were also more common in the ICT group. Continuous veno-venous hemofiltration during surgery (odds ratio [OR] 8.20, 95% confidence interval [CI]: 2.09–38.1; P = 0.004) was associated with ICT development. ICT was associated with markedly higher rates of cardiac arrest ( P < 0.001) and intraoperative mortality ( P < 0.001), with thrombus location in the left heart chambers representing a significant predictor of mortality (OR 20.7, 95% CI: 6.25–81.3; P < 0.001). ICT grades 2 and 3 were associated with a markedly increased risk of intraoperative cardiac arrest ( P < 0.05). Importantly, delayed use of TEE was strongly associated with intraoperative death (OR 6.27, 95% CI: 1.45–27.1; P = 0.014). The 90-day mortality was 43% in ICT cases compared to 4.5% in controls, while 1-year mortality was 46% versus 10.5%, respectively. Conclusions: ICT during LT is a rare but severe complication associated with intraoperative mortality and poor short-term survival. Coagulation profile and intraoperative management play critical roles in ICT development. The early use of TEE enables timely diagnosis and intervention, improving patient outcomes. We propose a novel ICT classification offering a systematic framework for risk stratification and management to mitigate progression and mortality.
Development and validation of natural language processing algorithms in the national ENACT network
Wang, Yanshan , Hilsman, Jordan, Li, Chenyu , Kwak, Min Ji , Applegate, Joseph R., Wang, Liwei , Harris, Daniel R. , Corbeau, Alexandria, Osborne, John D. , Kennedy, Richard , Garduno-Rapp, Nelly-Estefanie, Rousseau, Justin F. , Murphy, Tyler J., Sohn, Sunghwan , Peng, Yifan , Pathak, Aman, Xia, Zongqi , Loguercio, Salvatore , Reís, Steven E. , Visweswaran, Shyam, Harris, Daniel , Fan, Jungwei , Kennedy, Richard E , Osborne, John D , Li, Chenyu , Wang, Yanshan , Rousseau, Justin F , Morris, Michele M. , Heider, Paul M. , Fu, Sunyang , Wen, Andrew , Applegate, Joseph R., Bernstam, Elmer V , Liu, Hongfang , Chang, Jack , Henderson, Darren W. , Osborne, John, Yan, Chao , Chen, You , Patel, Mayur Bipin , Murphy, Tyler J., Malin, Bradley , Park, Chan Mi , Fan, Jungwei , Pagali, Sandeep R. , Wu, Yonghui , Visweswaran, Shyam

Mayo Clinic

Journal of Clinical and Translational Science | August 22, 2025 | Volume: 9 | Issue: 1 | Pages: No page available

10.1017/cts.2025.10116 | PMID 40979101 Get It

Abstract Objective: Electronic Health Record (EHR) data are critical for advancing translational research and AI technologies. The ENACT network offers access to structured EHR data across 57 CTSA hubs. However, substantial information is contained in clinical narratives, requiring natural language processing (NLP) for research. The ENACT NLP Working Group was formed to make NLP-derived clinical information accessible and queryable across the network. Methods: We established the ENACT NLP Working Group with 13 sites selected based on criteria including clinical notes access, IT infrastructure, NLP expertise, and institutional support. We divided sites into five focus groups targeting clinical tasks within disease contexts. Each focus group consisted of two development sites and two validation sites. We extended the ENACT ontology to standardize NLP-derived data and conducted multisite evaluations using the Open Health Natural Language Processing (OHNLP) Toolkit. Results: The working group achieved 100% site retention and deployed NLP infrastructure across all sites. We developed and validated NLP algorithms for rare disease phenotyping, social determinants of health, opioid use disorder, sleep phenotyping, and delirium phenotyping. Performance varied across sites (F1 scores 0.53–0.96), highlighting data heterogeneity impacts. We extended the ENACT common data model and ontology to incorporate NLP-derived data while maintaining Shared Health Research Informatics NEtwork (SHRINE) compatibility. Conclusion: This demonstrates feasibility of deploying NLP infrastructure across large, federated networks. The focus group approach proved more practical than general-purpose approaches. Key lessons include the challenge of data heterogeneity and importance of collaborative governance. This work also provides a foundation that other networks can build on to implement NLP capabilities for translational research.
Mice with mono-allelic p.R37H Dhdds variant show aberrant glycosylation and interneuron deficits
Silva, Afitz Da , Fallah, Merrick S. , Tadoum, Samuel Boris Tene, Fazeli, Mehrnaz, Muffels, Irena , Wang, Siyan , Grenier, François, Fazeli, M.S., Messina, Angela , Taherzadeh, Mahsa , Khan, Shaukat , Vruchte, Daniëlle te , Cristo, Graziella Di , Hamdan, Fadi F. , Platt, Frances M. , Pshezhetsky, Alexey V., Yamanaka, Yojiro , Haitin, Yoni , Rossignol, Elsa , Pshezhetsky, Alexey V , Muffels, I J J , Budhraja, Rohit , Sturiale, Luisa , Giladi, Moshe , Bonneil, Éric , Cristo, Graziella Di , Tomatsu, Shunji , Kozicz, Tamás , Thibault, Pierre , Garozzo, Domenico , Pandey, Akhilesh , Morava, Éva

Mayo Clinic

No container title available | August 21, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.08.15.670547 | PMID 40894730 Get It

Abstract Developmental delay and seizures with or without movement abnormalities (OMIM 617836) caused by heterozygous pathogenic variants in the DHDDS gene (DHDDS-CDG) is a rare genetic disease that belongs to the progressive encephalopathy spectrum. It results in cognitive delay in affected children, accompanied by myoclonus, seizures, ataxia and tremor, which worsens over time. DHDDS encodes a subunit of a DHDDS/NUS1 cis-prenyltransferase ( cis- PTase), a branch point enzyme of the mevalonate pathway essential for N-linked glycosylation. We describe the first mouse model of this disease, Dhdds R37H+/- strain, heterozygous for the human recurrent de novo c.110G>A:p.R37H pathogenic variant. Dhdds R37H+/- mice present with seizures, myoclonus and memory deficits associated with reduced density or/and maturity of inhibitory interneurons in the cortex. Multiomics analyses of mouse CNS tissues, together with the enzymatic/structural characterization of the R37H DHDDS mutant protein, reveal that the variant produces a catalytically inactive enzyme and results in a brain dolichol deficit, aberrant glycosylation of brain glycoproteins, including those involved in synaptic transmission and major perturbations in the CNS proteome and lipidome. Acetazolamide, a carbonic anhydrase inhibitor clinically approved for treatment of glaucoma, epilepsy, and intracranial hypertension, and successfully used “off-label” to treat genetic movement disorders, reduces seizure susceptibility to pentylenetetrazol in Dhdds R37H+/- mice, suggesting potential therapeutic value of using this drug in human DHDDS-CDG patients. Together, our results define cis- PTase as a master regulator of CNS development and function and establish that its monoallelic debilitating variants cause a novel congenital disorder of glycosylation associated with aberrant levels of neuronal proteins and lipids.
DataMorpher: Automatic Data Transformation Using LLM-Based Zero-Shot Code Generation
Sharma, Ankita , Tandel, Jaykumar , Li, Xuanmao, Zhang, Liang , Naqvi, Syed Arsalan Ahmed , Zou, Jia , Wang, Lanjun , Fariha, Anna , Riaz, Irbaz Bin , Cao, Lei

Mayo Clinic

2025 IEEE 41st International Conference on Data Engineering (ICDE) | August 20, 2025 | Volume: No volume available | Issue: No issue available | Pages: 4536-4539

10.1109/icde65448.2025.00346 Get It